EKOS超声辅助溶栓治疗中高危肺栓塞的PERT引导队列研究
该单中心回顾性研究纳入128例中高危肺栓塞患者,在PERT路径下接受EKOS超声辅助导管定向溶栓。干预后RV/LV比值与生物标志物显著改善,60天生存概率96.9%,院内恶化主要与基线疾病严重程度相关。
要点
- EKOS治疗后RV/LV比值中位数从1.6降至1.0,BNP从2365降至877 pg/mL。
- 60天生存概率为96.9%,短期生存良好。
- 院内需升级器官支持的恶化主要与基线疾病严重程度相关。
核心结论
- 在真实世界PERT引导队列中,EKOS与中高危肺栓塞患者快速生理改善和良好短期生存相关。
- 研究结果为描述性单中心经验,需谨慎解读。
研究设计与样本
- 回顾性单中心分析,纳入2017年8月至2023年12月连续128例急性中高危肺栓塞患者。
- 所有患者在结构化PERT路径下接受EKOS引导的超声辅助导管定向溶栓。
主要发现
- 干预后RV/LV比值和生物标志物显著改善,RV/LV比值中位数从1.6降至1.0(P < .001)。
- BNP从2365降至877 pg/mL(P < .001)。
- 部分患者发生需升级器官支持的临床有意义院内恶化,主要与基线疾病严重程度相关。
- 60天生存概率为96.9%。
关键数值与推荐
- 复合终点包括死亡、ECMO、肾脏替代治疗或有创机械通气。
- 多变量逻辑回归用于识别复合终点的决定因素。
临床怎么用
- 对于中高危肺栓塞患者,在PERT路径下可考虑EKOS超声辅助溶栓以快速改善右心功能和生物标志物。
- 需关注基线疾病严重程度高的患者,其院内恶化风险较高。
局限性
- 回顾性单中心设计,结果应作为描述性经验解读。
- 样本量有限,未设对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Acute intermediate-high-risk pulmonary embolism (PE) is associated with right-ventricular (RV) dysfunction, biomarker elevation, and risk of early clinical deterioration. Ultrasound-assisted catheter-directed thrombolysis (USAT) using the Eko Sonic Endovascular System (EKOS) system is increasingly used in selected patients; however, real-world data on physiological response and clinically relevant in-hospital outcomes remain limited. METHODS: We conducted a retrospective single-centre analysis of 128 consecutive patients with acute intermediate-high-risk PE treated with EKOS-guided USAT within a structured Pulmonary Embolism Response Team (PERT) pathway between August 2017 and December 2023. Changes in RV/LV ratio, B-type natriuretic peptide (BNP), and cardiac troponin before and after intervention were assessed. A composite end-point of death, extracorporeal membrane oxygenation (ECMO), renal replacement therapy, or invasive mechanical ventilation captured clinically meaningful deterioration. Multivariable logistic regression identified determinants of the composite end-point. RESULTS: RV/LV ratio and biomarkers improved significantly after intervention. Median RV/LV ratio decreased from 1.6 to 1.0, and BNP declined from 2365 to 877 pg/mL (both P < .001). Clinically meaningful in-hospital deterioration requiring escalation of organ support occurred in a subset of patients and was predominantly associated with baseline disease severity. Short-term survival remained favourable (60-day probability 96.9%). CONCLUSIONS: In this real-world, PERT-guided cohort, EKOS was associated with rapid physiological improvement and favourable short-term survival in patients with intermediate-high-risk PE. These findings should be interpreted as descriptive single-centre experience.
引用
- Ali MNHE, Zayat R, Hatam N, et al. Outcomes of EKOS (Ultrasound-Assisted Thrombolysis) for Intermediate-High-Risk Pulmonary Embolism: A PERT-Guided Cohort Study. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 42234536. doi:10.1093/icvts/ivag168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。